Envoy Medical, Inc. (NASDAQ:COCH) Director Purchases $13,320.00 in Stock

Envoy Medical, Inc. (NASDAQ:COCH) Director Mona Chetan Patel purchased 4,000 shares of the company’s stock in a transaction dated Wednesday, September 11th. The shares were acquired at an average price of $3.33 per share, with a total value of $13,320.00. Following the transaction, the director now owns 5,000 shares in the company, valued at approximately $16,650. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Mona Chetan Patel also recently made the following trade(s):

• On Monday, September 9th, Mona Chetan Patel acquired 1,000 shares of Envoy Medical stock. The shares were bought at an average cost of $3.20 per share, with a total value of $3,200.00.

Envoy Medical Stock Down 2.4 %

Shares of NASDAQ:COCH opened at $3.27 on Friday. Envoy Medical, Inc. has a 12-month low of $0.75 and a 12-month high of $11.72. The stock’s 50-day moving average price is $2.62 and its 200-day moving average price is $3.56.

Envoy Medical (NASDAQ:COCH) last announced its quarterly earnings data on Monday, August 12th. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.24) by ($0.03). The business had revenue of $0.07 million during the quarter, compared to analysts’ expectations of $0.08 million. On average, equities research analysts predict that Envoy Medical, Inc. will post -1.36 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Ascendiant Capital Markets boosted their target price on Envoy Medical from $8.50 to $8.75 and gave the stock a “buy” rating in a research report on Tuesday, September 3rd.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of COCH. Virtu Financial LLC purchased a new stake in Envoy Medical in the first quarter worth $55,000. Weiss Asset Management LP bought a new position in Envoy Medical in the 4th quarter worth $37,000. Finally, WealthTrust Asset Management LLC purchased a new stake in shares of Envoy Medical in the 1st quarter worth about $44,000. Hedge funds and other institutional investors own 8.59% of the company’s stock.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.